Nuveen Portfolio holdings
Nuveen is the asset management arm of TIAA, a financial services group long focused on retirement savings for universities, other not-for-profit institutions and their employees. Nuveen manages all of TIAA's capital as well as money from outside investors, and began in Chicago in 1898 as John Nuveen & Company, an investment bank founded by John Nuveen Sr. to underwrite and sell municipal bonds. Its funds cover income, equity, real estate and real assets such as farmland and timberland, alongside private equity and private debt, and Nuveen and TIAA often invest their own money alongside clients. A private equity group led by Madison Dearborn Partners bought the firm in 2007, and it merged with TIAA in 2014.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.96B |
| 2 |
Advanced Micro Devices
AMD
|
+$1.24B |
| 3 |
NVIDIA
NVDA
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$637M |
| 5 |
ServiceNow
NOW
|
+$597M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.62B |
| 2 |
Amazon
AMZN
|
+$824M |
| 3 |
Palo Alto Networks
PANW
|
+$604M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$532M |
| 5 |
Amphenol
APH
|
+$511M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.64% |
| 2 | Financials | 10.55% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Communication Services | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3626
inTEST
INTT
$175M
| $295K | ﹤0.01% |
24,896
+1,171
| +5% | +$14.9K |
2026 Q2
1 quarter
|
|
3627
iShares US Healthcare ETF
IYH
$4.82B
| $294K | ﹤0.01% |
4,064
+559
| +16% | +$39.4K |
2026 Q2
1 quarter
|
|
3628
Cognyte Software
CGNT
$637M
| $292K | ﹤0.01% |
34,408
+12,241
| +55% | +$107K |
2026 Q2
1 quarter
|
|
3629
Invesco Municipal Trust
VKQ
$505M
| $292K | ﹤0.01% |
34,447
+1,823
| +6% | +$17.5K |
2023 Q4
11 quarters
|
|
3630
GBank Financial Holdings
GBFH
$226M
| $291K | ﹤0.01% |
16,022
+3,920
| +32% | +$92.4K |
2025 Q2
5 quarters
|
|
3631
PayPay
PAYP
$10.4B
| $291K | ﹤0.01% |
+18,388
| New | +$292K |
2026 Q3
0 quarters
|
|
3632
Invesco Municipal Opportunity Trust
VMO
$614M
| $290K | ﹤0.01% |
34,771
+2,212
| +7% | +$21.1K |
2023 Q4
11 quarters
|
|
3633
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
$498M
| $289K | ﹤0.01% |
+2,408
| New | +$302K |
2026 Q3
0 quarters
|
|
3634
Avantis Emerging Markets Value ETF
AVES
$1.45B
| $288K | ﹤0.01% |
4,400
-300
| -6% | -$19.5K |
2026 Q2
1 quarter
|
|
3635
TriSalus Life Sciences
TLSI
$198M
| $288K | ﹤0.01% |
66,896
+2,998
| +5% | +$14.2K |
2025 Q2
5 quarters
|
|
3636
Militia Long/Short Equity ETF
ORR
$357M
| $287K | ﹤0.01% |
+7,637
| New | +$291K |
2026 Q3
0 quarters
|
|
3637
BNY Mellon Strategic Municipals
LEO
$379M
| $286K | ﹤0.01% |
51,503
| – | – |
2023 Q4
11 quarters
|
|
3638
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.73B
| $286K | ﹤0.01% |
+7,638
| New | +$295K |
2026 Q3
0 quarters
|
|
3639
Lineage Cell Therapeutics
LCTX
$273M
| $286K | ﹤0.01% |
298,853
+53,469
| +22% | +$59.1K |
2026 Q2
1 quarter
|
|
3640
Vanguard S&P 500 Growth ETF
VOOG
$26B
| $285K | ﹤0.01% |
+3,336
| New | +$278K |
2026 Q3
0 quarters
|
|
3641
Invesco Ultra Short Duration ETF
GSY
$4.01B
| $283K | ﹤0.01% |
+5,671
| New | +$284K |
2026 Q3
0 quarters
|
|
3642
Sionna Therapeutics
SION
$161M
| $280K | ﹤0.01% |
53,199
+11,940
| +29% | +$274K |
2025 Q2
5 quarters
|
|
3643
Century Therapeutics
IPSC
$328M
| $280K | ﹤0.01% |
163,592
| – | – |
2026 Q2
1 quarter
|
|
3644
Westwood Holdings Group
WHG
$178M
| $279K | ﹤0.01% |
14,963
+206
| +1% | +$3.97K |
2026 Q2
1 quarter
|
|
3645
Galectin Therapeutics
GALT
$349M
| $278K | ﹤0.01% |
71,721
+8,011
| +13% | +$31K |
2026 Q2
1 quarter
|
|
3646
Strategas Global Policy Opportunities ETF
SAGP
$78.9M
| $276K | ﹤0.01% |
7,874
+1,789
| +29% | +$65.5K |
2026 Q2
1 quarter
|
|
3647
Angel Oak UltraShort Income ETF
UYLD
$1.44B
| $276K | ﹤0.01% |
+5,415
| New | +$276K |
2026 Q3
0 quarters
|
|
3648
Direxion Daily NYSE FANG+ Bull 2X ETF
FNGG
$95M
| $275K | ﹤0.01% |
+1,000
| New | +$252K |
2026 Q3
0 quarters
|
|
3649
Goldman Sachs MarketBeta US Equity ETF
GSUS
$3.46B
| $275K | ﹤0.01% |
+2,598
| New | +$273K |
2026 Q3
0 quarters
|
|
3650
OP Bancorp
OPBK
$223M
| $273K | ﹤0.01% |
18,191
-3,028
| -14% | -$46.3K |
2025 Q2
5 quarters
|
|
Similar funds
Nuveen's Q3 2026 Portfolio in Review
As of Q3 2026, Nuveen held 5,174 positions worth $420B, up 0.31% from $419B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Nuveen's Q3 2026 filing shows 1,443 new, 2,311 increased, 1,275 reduced and 61 closed positions. Its largest new stake was Csquare: 2,675,408 shares worth $42.3M. The largest sale was Apple, an estimated $1.62B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q3 2026 buy was Csquare: 2,675,408 shares worth $42.3M.
- Nuveen added most to Micron Technology in Q3 2026, an estimated $1.96B increase.
- Nuveen's biggest Q3 2026 reduction was Apple, cutting an estimated $1.62B.
- Nuveen fully exited Electronic Arts in Q3 2026, selling an estimated $260M.
- Nuveen's ten largest holdings make up 34% of its $420B portfolio in Q3 2026.
- Nuveen opened 1,443 new positions and closed 61 in Q3 2026.
- Nuveen's portfolio value rose 0.31% quarter-over-quarter to $420B.
Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.